DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02181 MABPHARM-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Guo Jianjun (54.00%)
CDH Fund V, L.P. (18.00%)
Link Best Capital Limited (5.18%)
Sector Health Care & Biotechnology
Web Site http://www.mabpharm.cn Tel (852) 3150-6788
Email info@mabpharm.net Fax (852) 3150-6728
Related Equities N/A
Principal Activities Principally engaged in the research, development and production of monoclonal antibody drugs for cancers and autoimmune diseases and the transfer of intellectual property.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top